GEN1d
Recipharm Expands Aseptic Filling Capabilities for Process Development, Pilot Scale, and Clinical Supply
The modular sterile filling system reportedly can deliver 500 to 50,000 units per batch specifically tailored for process development.
The American Journal of Managed Care1d
Dr Jeff Stark: New Bimzelx Dose Offers Simplicity and Choice
On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.
FDA approves Susvimo for diabetic macular edema
The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...
Roche announces FDA approves Susvimo to treat DME
Roche (RHHBY) announced that the Food and Drug Administration has approved Susvimo 100 mg/mL for the treatment of diabetic macular edema, a ...